Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
6.28
-0.14 (-2.18%)
At close: Nov 20, 2024, 4:00 PM
6.12
-0.16 (-2.55%)
After-hours: Nov 20, 2024, 7:44 PM EST
Biomea Fusion Employees
Biomea Fusion had 103 employees as of December 31, 2023. The number of employees increased by 20 or 24.10% compared to the previous year.
Employees
103
Change (1Y)
20
Growth (1Y)
24.10%
Revenue / Employee
n/a
Profits / Employee
-$1,398,136
Market Cap
227.58M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 103 | 20 | 24.10% |
Dec 31, 2022 | 83 | 32 | 62.75% |
Dec 31, 2021 | 51 | 39 | 325.00% |
Dec 31, 2020 | 12 | - | - |
Related Stocks
Company Name | Employees |
---|---|
ModivCare | 21,200 |
Aurora Cannabis | 1,073 |
Inogen | 834 |
LifeMD | 211 |
Zentalis Pharmaceuticals | 124 |
aTyr Pharma | 59 |
Cybin | 50 |
Eledon Pharmaceuticals | 20 |
BMEA News
- 16 days ago - The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Biomea Fusion, Inc. For Securities Law Violations - Accesswire
- 17 days ago - Biomea Fusion Inc Is Being Investigated For Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm - Accesswire
- 18 days ago - The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Biomea Fusion, Inc. For Securities Law Violations - Accesswire
- 19 days ago - Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Biomea Fusion Inc Is Being Investigated For Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm - Accesswire
- 21 days ago - Biomea Fusion Presents Preclinical Data Showing Icovamenib (BMF-219) Enhanced Effectiveness of GLP-1-Based Therapies and Introduces BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist Candidate - GlobeNewsWire
- 21 days ago - The Schall Law Firm Urges Stockholders To Help With An Inquiry Into Biomea Fusion, Inc. For Securities Law Violations - Accesswire
- 22 days ago - Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate Highlights - GlobeNewsWire